secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neumora Therapeutics, Inc. (NMRA)
CIK:        0001885522
Form:       8-K
Filed at:   2023-09-19T23:59:59+00:00
Accession:  0001193125-23-237644
Event type: other_material
Sentiment:  positive
Materiality: 1.00
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neumora Therapeutics closes IPO: 14.71M shares at $17, gross proceeds ~$250.1M
------------------------------------------------------------------------------

- Completed IPO of 14,710,000 shares of common stock at $17.00 per share on September 19, 2023.
- Gross proceeds of approximately $250.1 million before underwriting discounts and expenses.
- Amended and restated certificate of incorporation and bylaws became effective with the IPO.
- Charter provisions include classified board, exclusive forum for derivative and securities claims, and no cumulative voting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1885522/000119312523237644/0001193125-23-237644-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1885522/000119312523237644/d541406d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-237644

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer